Management of infection risk to myeloma patients during the COVID pandemic

Bookmark and Share
Published: 1 Oct 2020
Views: 3183
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria

Prof Heinz Ludwig talks to ecancer about his presentation at the MyKE20 virtual meeting.

He initially talks about infections in myeloma patients, covering the risks and also management of these infections.

Following on this topic, Prof Ludwig talks about the COVID pandemic risk to myeloma patients.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.